Civic Intelligence

Frontiers in Bioscience Inc.

990 • Fiscal year 2014 • EIN 59-3432665

Jan 01, 2014 to Dec 31, 2014 • Filed on May 12, 2015

20 Sunset CoveNewport Coast, CA 92657

(949) 715-8286

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

26th percentile

0.04x

Higher debt load relative to assets than 26% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Liabilities / Revenue

61st percentile

0.30x

Higher debt load relative to revenue than 61% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Net Margin

87th percentile

37%

Higher net margin than 87% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Top Officer Pay

34th percentile

$86,672

Higher top officer pay than 34% of similar nonprofits.

Top officer pay equals 9.3% of source-year revenue.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Asset Growth

58th percentile

5.1%

Faster asset growth than 58% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2013 to 2014

Revenue Growth

20th percentile

-8.9%

Faster revenue growth than 20% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2013 to 2014

Assets

Up

$7,380,585

Up $361,155 (+5.1%) from 2013

Net Assets

Up

$7,101,439

Up $240,302 (+3.5%) from 2013

Liabilities

Up

$279,146

Up $120,853 (+76%) from 2013

Revenue

Down

$929,379

Down $90,989 (-8.9%) from 2013

Expenses

Down

$583,280

Down $8,386 (-1.4%) from 2013

Net Income

Down

$346,099

Down $82,603 (-19%) from 2013

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2014

Assets$7,380,585
Liabilities$279,146
Net Assets$7,101,439

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2014

Revenue$929,379
Expenses$583,280
Net Income$346,099
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
May 12, 2015
Return Version
2014v5.0
Gross Receipts
$929,379
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or dece

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$3,979,922$4,414,641▲ $434,719
Land, Buildings, and Equipment, Net$3,021,707$2,953,105▼ $68,602
Loans From Officers Directors$145,555$251,396▲ $105,841
Other Notes and Loans Receivable, Net$13,141$8,179▼ $4,962
Investments in Publicly Traded Securities$4,660$4,660→ $0
Total Assets$7,019,430$7,380,585▲ $361,155
Liabilities
Accounts Payable and Accrued Expenses$12,738$27,750▲ $15,012
Total Liabilities$158,293$279,146▲ $120,853
Net Assets / Fund Balance
Unrestricted Net Assets$6,861,137$7,101,439▲ $240,302
Total Net Assets Fund Balance$6,861,137$7,101,439▲ $240,302
Total Liabilities and Net Assets / Fund Balance$7,019,430$7,380,585▲ $361,155

Asset Categories

AssetBook ValueDepreciationBasis
Buildings$1,245,280$190,035$853,485
Land$1,630,474-$374,293
Equipment$47,103$249,944$297,047
Other Land Buildings$30,248$39,807$70,055
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Siamak Tabibzadeh MdPresident/cePT$80,000$6,672$86,672

Board Members and Trustees

NameTitle
Bruce HoumanDirector
Masood KashanchiDirector
Daniel TabibzadehSecretary
Jennifer TabibzadehTreasurer/cf
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$923,465
Investment Income
$5,914
Other Revenue
$0
Change in Net Assets
$346,099
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$295,128
Other Expenses$288,152
Total Fundraising Expense$12,279
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$172,334--$172,334
Current Officers, Directors, Trustees, and Key Employees$64,000$8,000$8,000$80,000
Depreciation Depletion$61,791--$61,791
All Other Expenses$34,346--$34,346
Payroll Taxes$21,752$2,719$2,719$27,190
Occupancy$16,164--$16,164
Other Employee Benefits$12,484$1,560$1,560$15,604
Fees for Services Other$9,997--$9,997
Office Expenses$9,754--$9,754
Other Expenses$7,547--$7,547
Fees for Services Accounting-$6,450-$6,450
Insurance$6,190--$6,190
Information Technology$4,701--$4,701
Travel$4,286--$4,286
Conferences and Meetings$234--$234
Total Functional Expenses$552,272$18,729$12,279$583,280
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Siamak TabibzadehCEOSalary Executive DirNo$80,000
Daniel TabibzadehSecretarySalary Admin DirNo-

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$145,555$251,396▲ $105,841
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Business relationship with family members
Yes
Business relationship with organization members
Yes
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 2

Siamak tabibzadeh daniel tabibzadeh presidentceo secretary father/son siamak tabibzadeh jennifer tabibzadeh presidentceo director father/daughter

Form 990, Page 6, Part VI, Line 11B

The form 990 is reviewed with the cpa consultant as to accuracy and completeness.

Form 990, Page 6, Part VI, Line 19

AVAIABLE UPON REQUEST.

Filing and Contact Details

Filer

Filer Name
Frontiers in Bioscience
EIN
59-3432665
Phone
9497158286
Address
20 SUNSET COVE, NEWPORT COAST, CA 92657

Signing Officer

Name
Siamak Tabibzadeh Md
Title
President
Phone
9497158286
Signed
2015-05-12

Organization Details

Principal Officer
Siamak Tabibzadeh
Formed
1995
Legal Domicile
Fl
Voting Board Members
5
Independent Board Members
2
Employees
5

Preparer

Firm
Invisible Accountantan Accountancy Corp
Address
300 SPECTRUM CENTER DR SUITE 970, IRVINE, CA 92618-4953
Preparer
Ardavan Keyhan CPA
Phone
9496541400
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.

Form 990, Page 2, Part III, Line 4A

Also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.

Form 990, Part XI, Line 9

Officer loan interest accrued-current -105,841 officer loan interest accrued-prior 94,799

Form 990, Part XI, Line 9

Officer loan interest accrual 94,755

Raw XML Appendix389 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt012738
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt027750
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE
IRS990/AllOtherExpensesGrp/ProgramServicesAmt034346
IRS990/AllOtherExpensesGrp/TotalAmt034346
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd092657
IRS990/BusinessRlnWithFamMemInd0true
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0true
IRS990/CashNonInterestBearingGrp/BOYAmt03979922
IRS990/CashNonInterestBearingGrp/EOYAmt04414641
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt08000
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt08000
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt064000
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt080000
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0234
IRS990/ConferencesMeetingsGrp/TotalAmt0234
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt05914
IRS990/CYOtherExpensesAmt0288152
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0923465
IRS990/CYRevenuesLessExpensesAmt0346099
IRS990/CYSalariesCompEmpBnftPaidAmt0295128
IRS990/CYTotalExpensesAmt0583280
IRS990/CYTotalFundraisingExpenseAmt012279
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0929379
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt061791
IRS990/DepreciationDepletionGrp/TotalAmt061791
IRS990/Desc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt05
IRS990/EmploymentTaxReturnsFiledInd0false
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0552272
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt06450
IRS990/FeesForServicesAccountingGrp/TotalAmt06450
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt09997
IRS990/FeesForServicesOtherGrp/TotalAmt09997
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt025.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt06672
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1DANIEL TABIBZADEH
IRS990/Form990PartVIISectionAGrp/PersonNm2JENNIFER TABIBZADEH
IRS990/Form990PartVIISectionAGrp/PersonNm3BRUCE HOUMAN
IRS990/Form990PartVIISectionAGrp/PersonNm4MASOOD KASHANCHI
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt080000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT/CE
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER/CF
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01995
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0929379
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt02
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt04701
IRS990/InformationTechnologyGrp/TotalAmt04701
IRS990/InsuranceGrp/ProgramServicesAmt06190
IRS990/InsuranceGrp/TotalAmt06190
IRS990/InvestmentIncomeGrp/ExclusionAmt05914
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt05914
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt04660
IRS990/InvestmentsPubTradedSecGrp/EOYAmt04660
IRS990/IRPDocumentCnt02
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0479786
IRS990/LandBldgEquipBasisNetGrp/BOYAmt03021707
IRS990/LandBldgEquipBasisNetGrp/EOYAmt02953105
IRS990/LandBldgEquipCostOrOtherBssAmt03432891
IRS990/LegalDomicileStateCd0FL
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0145555
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0251396
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt06861137
IRS990/NetAssetsOrFundBalancesEOYAmt07101439
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ProgramServicesAmt016164
IRS990/OccupancyGrp/TotalAmt016164
IRS990/OfficeExpensesGrp/ProgramServicesAmt09754
IRS990/OfficeExpensesGrp/TotalAmt09754
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-105797
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt01560
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt01560
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt012484
IRS990/OtherEmployeeBenefitsGrp/TotalAmt015604
IRS990/OtherExpensesGrp/Desc0LABORATORY SUPPLIES/FEES
IRS990/OtherExpensesGrp/Desc1PROPERTY TAXES
IRS990/OtherExpensesGrp/Desc220 SUNSET COVE - BUILDING
IRS990/OtherExpensesGrp/Desc31080 PARK - BUILDING
IRS990/OtherExpensesGrp/ProgramServicesAmt070623
IRS990/OtherExpensesGrp/ProgramServicesAmt142459
IRS990/OtherExpensesGrp/ProgramServicesAmt213610
IRS990/OtherExpensesGrp/ProgramServicesAmt37547
IRS990/OtherExpensesGrp/TotalAmt070623
IRS990/OtherExpensesGrp/TotalAmt142459
IRS990/OtherExpensesGrp/TotalAmt213610
IRS990/OtherExpensesGrp/TotalAmt37547
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0172334
IRS990/OtherSalariesAndWagesGrp/TotalAmt0172334
IRS990/OthNotesLoansReceivableNetGrp/BOYAmt013141
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt08179
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt02719
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt02719
IRS990/PayrollTaxesGrp/ProgramServicesAmt021752
IRS990/PayrollTaxesGrp/TotalAmt027190
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0CHECKS/WIRES-UNIVERSITIES
IRS990/ProgramServiceRevenueGrp/Desc1MERCHANT CARD PAYMENTS
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0598236
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt1325229
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0598236
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt1325229
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt07546
IRS990/PYOtherExpensesAmt0301628
IRS990/PYProgramServiceRevenueAmt01012822
IRS990/PYRevenuesLessExpensesAmt0428702
IRS990/PYSalariesCompEmpBnftPaidAmt0290038
IRS990/PYTotalExpensesAmt0591666
IRS990/PYTotalRevenueAmt01020368
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt0346099
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt05914
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt07546
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt012028
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt014686
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt017603
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt057777
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0923465
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt01012822
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt01060446
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt01246544
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0889590
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt05132867
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt05914
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt07546
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt012028
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt014686
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt017603
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt057777
IRS990ScheduleA/InvestmentIncomeCYPct00.01000
IRS990ScheduleA/InvestmentIncomePYPct00.02000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.98890
IRS990ScheduleA/PublicSupportPY509Pct00.97950
IRS990ScheduleA/PublicSupportTotal509Amt05132867
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0923465
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt01012822
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt01060446
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt01246544
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0889590
IRS990ScheduleA/Total509Grp/TotalAmt05132867
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0929379
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt01020368
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt01072474
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt01261230
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0907193
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt05190644
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt01245280
IRS990ScheduleD/BuildingsGrp/DepreciationAmt0190035
IRS990ScheduleD/BuildingsGrp/InvestmentCostOrOtherBasisAmt0581830
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt0853485
IRS990ScheduleD/EquipmentGrp/BookValueAmt047103
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0249944
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0297047
IRS990ScheduleD/LandGrp/BookValueAmt01630474
IRS990ScheduleD/LandGrp/InvestmentCostOrOtherBasisAmt01256181
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt0374293
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt030248
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt039807
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt070055
IRS990ScheduleD/TotalBookValueLandBuildingsAmt02953105
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm0SIAMAK TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm1DANIEL TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt0CEO
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt1SECRETARY
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd1false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt080000
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc0SALARY EXECUTIVE DIR
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc1SALARY ADMIN DIR
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt0251396
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0154000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0SIAMAK TABIBZADEH PROMISSORY NOTE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0CEO
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/SupplementalInformationDetail/ExplanationTxt0PERSONAL LOAN TO PURCHASE ASSETS
IRS990ScheduleL/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE L, PART V
IRS990ScheduleL/TotalBalanceDueAmt0251396
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2SIAMAK TABIBZADEH DANIEL TABIBZADEH PRESIDENTCEO SECRETARY FATHER/SON SIAMAK TABIBZADEH JENNIFER TABIBZADEH PRESIDENTCEO DIRECTOR FATHER/DAUGHTER
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE FORM 990 IS REVIEWED WITH THE CPA CONSULTANT AS TO ACCURACY AND COMPLETENESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4AVAIABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5OFFICER LOAN INTEREST ACCRUED-CURRENT -105,841 OFFICER LOAN INTEREST ACCRUED-PRIOR 94,799
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6OFFICER LOAN INTEREST ACCRUAL 94,755
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART XI, LINE 9
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt07019430
IRS990/TotalAssetsEOYAmt07380585
IRS990/TotalAssetsGrp/BOYAmt07019430
IRS990/TotalAssetsGrp/EOYAmt07380585
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt05
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt012279
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt018729
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0552272
IRS990/TotalFunctionalExpensesGrp/TotalAmt0583280
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0158293
IRS990/TotalLiabilitiesEOYAmt0279146
IRS990/TotalLiabilitiesGrp/BOYAmt0158293
IRS990/TotalLiabilitiesGrp/EOYAmt0279146
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt06861137
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt07101439
IRS990/TotalOtherCompensationAmt06672
IRS990/TotalProgramServiceExpensesAmt0552272
IRS990/TotalProgramServiceRevenueAmt0923465
IRS990/TotalReportableCompFromOrgAmt080000
IRS990/TotalRevenueGrp/ExclusionAmt05914
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0923465
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0929379
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt07019430
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt07380585
IRS990/TravelGrp/ProgramServicesAmt04286
IRS990/TravelGrp/TotalAmt04286
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt06861137
IRS990/UnrestrictedNetAssetsGrp/EOYAmt07101439
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/USAddress/CityNm0NEWPORT COAST
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd092657
IRS990/VotingMembersGoverningBodyCnt05
IRS990/VotingMembersIndependentCnt02
IRS990/WebsiteAddressTxt0WWW.BIOSCIENCE.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02016-02-25 16:41:14Z
ReturnHeader/BusinessOfficerGrp/PersonNm0SIAMAK TABIBZADEH MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum09497158286
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-05-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0FRONTIERS IN BIOSCIENCE
ReturnHeader/Filer/BusinessNameControlTxt0FRON
ReturnHeader/Filer/EIN0593432665
ReturnHeader/Filer/PhoneNum09497158286
ReturnHeader/Filer/USAddress/AddressLine1Txt020 SUNSET COVE
ReturnHeader/Filer/USAddress/CityNm0NEWPORT COAST
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092657
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330837084
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0INVISIBLE ACCOUNTANTAN ACCOUNTANCY CORP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0300 SPECTRUM CENTER DR SUITE 970
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0IRVINE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0926184953
ReturnHeader/PreparerPersonGrp/PhoneNum09496541400
ReturnHeader/PreparerPersonGrp/PreparationDt02015-05-13
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ARDAVAN KEYHAN CPA
ReturnHeader/ReturnTs02015-05-13T18:39:50-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.94$0.04$7.90$0.88$0.56$0.32
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30